谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Prognostic Value of the Fluctuation in the Neutrophil-Lymphocyte Ratio at 6 Weeks of Pembrolizumab Treatment is Specific to the Clinical Response in Metastatic Urothelial Carcinoma

Taizo Uchimoto,Ko Nakamura,Kazumasa Komura,Wataru Fukuokaya,Yusuke Yano,Kazuki Nishimura,Shoko Kinoshita,Kyosuke Nishio,Tatsuo Fukushima,Keita Nakamori,Tomohisa Matsunaga,Takeshi Tsutsumi,Takuya Tsujino,Kohei Taniguchi,Tomohito Tanaka,Hirofumi Uehara,Kiyoshi Takahara,Teruo Inamoto,Takahiro Kimura,Shin Egawa,Haruhito Azuma

Urologic Oncology Seminars and Original Investigations（2022）

引用 8|浏览18
暂无评分
关键词
Pembrolizumab,Overall survival,Urothelial carcinoma,Prognostic factor,Objective response rate,Neutrophil - lymphocyte ratio
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要